Tribune and McClatchy are both approaching critical deadlines that could lead to mergers, divisions — or even the first big nonprofit newspaper chain in the United States.
By selling Berkshire Hathaway’s newspapers to Lee Enterprises, the world’s most successful investor is acknowledging the industry’s downhill slide is not near an end.
The number of employees soon to be cut at the No. 1 U.S. newspaper chain is about the same number as the No. 2 chain has in total. But newsrooms should mostly be spared — for now.
What will the largest local news company need to do and be to be successful in the 2020s? Neither Gannett nor Gatehouse has offered any big vision of what that is, or could be, even fueled by new money.
The merger of the United States’ No. 1 and No. 2 newspaper chains will likely spark a new wave of consolidation among its smaller competitors. But will the potential cost savings be eaten up by debt payments to financiers?
Doctor, Ken. "Newsonomics: 8 questions as Michael Ferro leaves the stage ($100 million richer)." Nieman Journalism Lab. Nieman Foundation for Journalism at Harvard, 16 Apr. 2018. Web. 27 May. 2023.
APA
Doctor, K. (2018, Apr. 16). Newsonomics: 8 questions as Michael Ferro leaves the stage ($100 million richer). Nieman Journalism Lab. Retrieved May 27, 2023, from https://www.niemanlab.org/2018/04/newsonomics-eight-questions-as-michael-ferro-leaves-the-stage-100m-richer/
Chicago
Doctor, Ken. "Newsonomics: 8 questions as Michael Ferro leaves the stage ($100 million richer)." Nieman Journalism Lab. Last modified April 16, 2018. Accessed May 27, 2023. https://www.niemanlab.org/2018/04/newsonomics-eight-questions-as-michael-ferro-leaves-the-stage-100m-richer/.
Wikipedia
{{cite web
| url = https://www.niemanlab.org/2018/04/newsonomics-eight-questions-as-michael-ferro-leaves-the-stage-100m-richer/
| title = Newsonomics: 8 questions as Michael Ferro leaves the stage ($100 million richer)
| last = Doctor
| first = Ken
| work = [[Nieman Journalism Lab]]
| date = 16 April 2018
| accessdate = 27 May 2023
| ref = {{harvid|Doctor|2018}}
}}
